Eko Analysis Software vs Mindbowser AI Cardiovascular Risk Prediction

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Eko Analysis Software is designed for the real-time detection of specific cardiovascular conditions like heart murmurs and atrial fibrillation, integrating with digital stethoscopes for immediate clinical assessment. In contrast, Mindbowser's AI Cardiovascular Risk Prediction tool focuses on assessing broader cardiovascular risks and providing clinical decision support through EHR integration. While both operate in cardiology AI, Eko aids in immediate diagnosis, whereas Mindbowser supports long-term risk stratification and patient management.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if your clinical practice requires immediate, AI-powered assistance during physical examinations to detect specific cardiovascular conditions like heart murmurs and atrial fibrillation. This tool is ideal for clinicians who utilize digital stethoscopes and need real-time analysis, recording, and visualization of heart sounds and ECGs to enhance diagnostic accuracy at the point of care.

View Eko Analysis Software →

Choose Mindbowser AI Cardiovascular Risk Prediction if…

Choose Mindbowser AI Cardiovascular Risk Prediction if your organization needs to integrate advanced AI-driven risk assessment directly into your existing EHR system for proactive population health management. This tool is best suited for hospitals and large clinics aiming to identify patients at high cardiovascular risk through comprehensive data analysis and to provide clinical decision support across their patient base.

View Mindbowser AI Cardiovascular Risk Prediction →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Mindbowser AI Cardiovascular Risk Prediction
Pricing Unknown Contact for pricing
Deployment Unknown Cloud-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software integrates with a mobile app and digital stethoscopes, offering a direct and intuitive user experience for clinicians at the point of care. Its freemium model also allows for easy access to basic features, lowering the barrier to entry.

Clinical Value

Eko Analysis Software

Eko Analysis Software holds specific FDA clearances for the detection of heart murmurs and atrial fibrillation, providing direct diagnostic assistance for critical cardiovascular conditions. Mindbowser's tool focuses on broader risk prediction, which is valuable but less direct in immediate diagnostic utility.

Pricing & Value

Eko Analysis Software

Eko Analysis Software offers a transparent freemium model with clear subscription tiers for full features, allowing users to understand costs upfront. Mindbowser's 'contact for pricing' approach lacks transparency, making it difficult to assess its value proposition without direct engagement.

Enterprise Readiness

Mindbowser AI Cardiovascular Risk Prediction

Mindbowser's AI Cardiovascular Risk Prediction explicitly highlights robust EHR integration with major systems like Epic, Cerner, and Athenahealth, along with HL7 and FHIR interoperability and SOC 2 compliance. These features demonstrate a strong focus on seamless integration and scalability within large healthcare organizations.

Innovation

Eko Analysis Software

Eko Analysis Software innovates by integrating AI directly with a physical diagnostic device (digital stethoscope) for real-time, point-of-care detection of specific cardiac conditions. This brings advanced diagnostic capabilities directly to the clinician's examination, enhancing immediate clinical insights.

Support & Docs

Eko Analysis Software

Eko provides extensive and publicly accessible support resources, including a dedicated Help Center, user manuals, FAQs, email and phone support, and live training sessions. Mindbowser, as an enterprise solutions provider, offers support as part of its engagements, but lacks the same level of transparent and readily available public documentation and support channels for its specific product.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Mindbowser AI Cardiovascular Risk Prediction
Tool Name Eko Analysis Software Mindbowser AI Cardiovascular Risk Prediction
Company Eko Devices Mindbowser
Description FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. Part of their comprehensive suite of healthcare AI solutions, designed for providers and hospitals to assess cardiovascular risks. It emphasizes compliance with HIPAA and SOC 2 and integrates with leading EHR systems.
Key AI Detections/Predictions FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm, Calculation of cardiac time intervals (heart rate, QRS duration) AI Cardiovascular Risk Prediction, AI-powered automation, Clinical Decision Support System
EHR Integration Not specified Yes (Epic, Cerner, Athenahealth, FHIR)
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Mindbowser AI Cardiovascular Risk Prediction.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software (Tool A) is an FDA-cleared AI-powered tool designed for the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, as well as identifying normal sinus rhythm and calculating cardiac time intervals. Mindbowser AI Cardiovascular Risk Prediction (Tool B) focuses on assessing overall cardiovascular risks, providing AI-powered automation and clinical decision support by leveraging patient data.
Eko Analysis Software (Tool A) integrates with Eko's digital stethoscopes and mobile app, enabling wireless auscultation and secure cloud-based storage of recordings. Mindbowser AI Cardiovascular Risk Prediction (Tool B) offers robust integration with leading EHR systems such as Epic, Cerner, and Athenahealth, and supports HL7 & FHIR interoperability for secure healthcare data access.
Both Eko Analysis Software (Tool A) and Mindbowser AI Cardiovascular Risk Prediction (Tool B) are HIPAA compliant and offer Business Associate Agreements (BAAs). Mindbowser's tool (Tool B) additionally emphasizes SOC 2 compliance, alongside HIPAA, for secure and compliant healthcare data access.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.